10.1002/chem.201704277
Chemistry - A European Journal
COMMUNICATION
between the synthetic and isolated skyllamycins A-C suggested
that they were the same enantiomer (see Supporting
Information). Finally, the synthetic natural products were
analyzed in a P. aeruginosa biofilm inhibition assay alongside
the authentic natural products. Pleasingly, the synthetic and
isolated products 1-3 showed comparable biofilm inhibition
activity, further confirming the identity of the synthetic natural
products (see Supporting Information).
H. Yildiz, R. G. Linington, Antimicrob. Agents Chemother. 2014,
58, 1092-1099.
[2]
[3]
a) S. Uhlmann, R. D. Süssmuth, M. J. Cryle, ACS Chem. Biol.
2013, 8, 2586-2596; b) K. Haslinger, C. Brieke, S. Uhlmann, L.
Sieverling, R. D. Süssmuth, M. J. Cryle, Angew. Chem. Int. Ed.
2014, 53, 8518-8522.
a) T. Takeuchi, H. Iinuma, S. Kunimoto, T. Masuda, M. Ishizuka,
M. Takeuchi, M. Hamada, H. Naganawa, S. Kondo, H. Umezawa,
J. Antibiot. 1981, 34, 1619-1621; b) H. Umezawa, S. Kondo, H.
Iinuma, S. Kunimoto, Y. Ikeda, H. Iwasawa, D. Ikeda, T. Takeuchi,
J. Antibiot. 1981, 34, 1622-1624.
In conclusion, we have successfully completed the first total
synthesis of skyllamycins A-C (1-3). A key final macrocyclization
step with concomitant formation of the unusual -OH-Gly moiety
was used to construct the natural products, which were identical
in all respects to isolated skyllamycins A-C. This work lays the
foundation for further studies into the biosynthesis of these
natural products, the generation of synthetic skyllamycin
analogues, as well as the interrogation of the mechanism of their
biofilm inhibitory activity. Studies toward this end will be reported
in due course.
[4]
[5]
[6]
[7]
V. Schubert, F. Di Meo, P. L. Saaidi, S. Bartoschek, H. P. Fiedler,
P. Trouillas, R. D. Süssmuth, Chem. Eur. J. 2014, 20, 4948-4955.
P. S. Stewart, J. William Costerton, The Lancet 2001, 358, 135-
138.
L. Lebreton, J. Annat, P. Derrepas, P. Dutartre, P. Renaut, J. Med.
Chem. 1999, 42, 277-290.
a) K. F. Geoghegan, J. G. Stroh, Bioconjugate Chem. 1992, 3,
138-146; b) O. El-Mahdi, O. Melnyk, Bioconjugate Chem. 2013,
24, 735-765.
[8]
P. Sieber, Tetrahedron Lett. 1987, 28, 2107-2110.
P. Garner, J. M. Park, J. Org. Chem. 1987, 52, 2361-2364.
a) L. Williams, Z. D. Zhang, F. Shao, P. J. Carroll, M. M. Joullié,
Tetrahedron 1996, 52, 11673-11694; b) N. Okamoto, O. Hara, K.
Makino, Y. Hamada, J. Org. Chem. 2002, 67, 9210-9215; c) A.
Nishida, H. Sorimachi, M. Iwaida, M. Matsumizu, T. Kawate, M.
Nakagawa, Synlett 1998, 389-390.
Acknowledgements
[9]
[10]
We thank Dr. Ian Luck and Dr. Nick Proschogo (University of
Sydney) for NMR spectroscopy and mass spectrometry
technical support, respectively, and Walter Bray (UC, Santa
Cruz) for support with the biofilm screening. We thank the
Australian Postgraduate Award and John A. Lamberton
Scholarship for PhD funding (A.M.G), ARC Future Fellowship to
R.J.P (FT130100150), and NSERC Discovery support to R.G.L.
(RGPIN-2016-03962).
[11]
[12]
[13]
[14]
T. Wöhr, F. Wahl, A. Nefzi, B. Rohwedder, T. Sato, X. Sun, M.
Mutter, J. Am. Chem. Soc. 1996, 118, 9218-9227.
S. Schabbert, M. D. Pierschbacher, R. H. Mattern, M. Goodman,
Bioorg. Med. Chem. 2002, 10, 3331-3337.
D. Sun, P. Lai, W. Xie, J. Deng, Y. Jiang, Synth. Commun. 2007,
37, 2989-2994.
R. Krishnamoorthy, L. D. Vazquez-Serrano, J. A. Turk, J. A.
Kowalski, A. G. Benson, N. T. Breaux, M. A. Lipton, J. Am. Chem.
Soc. 2006, 128, 15392-15393.
Keywords: solid-phase synthesis • natural products • biofilms •
peptides • cyclic peptides
[15]
[16]
C. Yue, J. Thierry, P. Potier, Tetrahedron Lett. 1993, 34, 323-326.
R. Subirós-Funosas, A. El-Faham, F. Albericio, Tetrahedron 2011,
67, 8595-8606.
[1]
a) S. Toki, T. Agatsuma, K. Ochiai, Y. Saitoh, K. Ando, S.
Nakanishi, N. A. Lokker, N. A. Giese, Y. Matsuda, J. Antibiot.
2001, 54, 405-414; b) S. Pohle, C. Appelt, M. Roux, H. P. Fiedler,
R. D. Süssmuth, J. Am. Chem. Soc. 2011, 133, 6194-6205; c) G.
Navarro, A. T. Cheng, K. C. Peach, W. M. Bray, V. S. Bernan, F.
This article is protected by copyright. All rights reserved.